In this paper we report the diagnosis of four cases of Plasmodium malariae in humans in Costa Rica, using parasitological and molecular techniques.
Introduction
The identification of the infecting Plasmodium species and sequence analysis from an outbreak in a new region or from imported cases is especially relevant for disease surveillance and decision making to identify possible sources of infection or reservoirs as well as for the therapeutic decision making and the development of control and prevention measures for the disease. For this reason, CNRP-INCIENSA introduced diagnostic methodologies like endpoint polymerase chain reaction (PCR) in 2009 and real-time PCR in 2011, which have contributed to molecular laboratory-based surveillance of malaria in Costa Rica. The use of real-time PCR allows results in approximately 3 hours, ensuring a timely and accurate diagnosis of infection and permits parasite quantification [1] .
Plasmodium malariae had not been detected in humans from
Costa Rica since 1959 [2] , although Plasmodium brasilianum was found in blood smears of howler monkeys (Alouatta palliata) of Costa Rica [3] . According to Collins and Jeffery [4] , South American monkeys are naturally infected with P. brasilianum, and the high genetic identity found between P. malariae and P. brasilianum suggests the occurrence of recent transfers between hosts [5] . Between 2012 and 2013, four human cases caused by P. malariae were diagnosed for the first time since 1959 in CNRP-INCIENSA [6, 7] . It has been reported, that blood stages of P. malariae persist for extremely long periods, often for the life of the human host. In this respect, there have been reported cases of people, who have left zones of endemicity and, either following donation of blood in which the recipient developed an infection, or whose infections have recrudesced after many years (up to 50 years) of dormancy under stress [4] . The objective of this paper was to confirm the finding of P. malariae in Costa Rica by using microscopic and molecular techniques.
Materials and Methods

Ethics statements
The Ethics Committee (Dirección Técnica) of INCIENSA approved a research car r ied out as a laborator y-based epidemiological surveillance of malaria, which is a strategic role of the National Reference Center for Parasitology (CNRP-INCIENSA). This committee reviewed the ethical content of the research project generated with the samples that were received from all health services of the country for their respective diagnosis and confirmation. It ensures that international ethical research standards were met, such as confidentiality, principle of individual autonomy (coded samples), and principle of beneficence (analysis and publication of data of diseases of mandatory notification, that are essential for decision-making in health). Apicomplexa, as Plasmodium spp [16] .
Size and type of samples
Results
In three out of four samples analyzed microscopically, P. malariae was identified. The concentrations of parasites and DNA in these samples are shown in Table 1 . However real-time PCR detected P. malariae in all four samples, and established absence of P. vivax and P. falciparum (Table 1, Figure 1 ). The number of amplification cycles required to reach the threshold of fluorescence were 24, 28, 37 and 28 for samples 1, 2, 3, and 4, respectively.
In three out of four samples sequence analysis was possible and phylogenetic tree confirmed the results obtained microscopically and by real-time PCR, identifying those samples as P. malariae/ brasilianum (Figure 2 and 3 ). BLASTn analysis resulted in a 99% identity between the samples, and 99% identity with P. malariae isolated from atypical human cases that occurred in Asia, and 99% identity with a sequence of P. brasilianum isolated from a nonhuman primate of Guiana, and that were deposited in GenBank (Table 2, Figure 3 and 4). Nucleotide sequences of samples 1, 2 and 4 were deposited in GenBank and received the accession numbers KJ934251, KJ934252 and KJ934253, respectively.
Discussion
In three samples (1, 2 and 4) P. malariae was detected microscopically, and all four samples tested positive for P. malariae by real-time PCR, which is in accordance with the detection limit of each technique. Routine clinical microscopy cannot reliably detect very low parasitemias (<5 to 10 parasites/ μl) [17] , whereas real-time PCR detects from 2 to 5 parasites/µl [1] .
Future studies, however, have to determine, if P. malariae is re-emerging in Costa Rica or has always been present these years. The use of modified Romanowsky as a staining method for malaria diagnosis was recommended by the Pan American Health Organization, World Health Organization and carried out from 1959 until 2013 in Costa Rica, because of its advantage of no need of prior dishemoglobinizing blood samples. However, disadvantages of this non-standard procedure is the poor differentiation of parasitic stages, when compared to Giemsa staining. Furthermore, malaria cases are detected in Costa Rica generally at early parasitological stages using blood smears, when immature trophozoites from different Plasmodium species are difficult to differentiate, especially using modified Romanowsky. For this reason, it is recommended to improve the quality of microscopic analysis in Costa Rica. Between 2013 and 2017 laboratories in Costa Rica will be trained in Giemsa staining, to improve the diagnosis and eliminate malaria from the country (Nidia Calvo, personal communication).
Sequence analysis of the three Costa Rican samples established a 99% of identity with two peculiar forms of P. malariae reported by Kawamoto et al. [18] whose early trophozoite stages resemble morphologically that of Plasmodium vivax, var. minuta and Plasmodium tenue, and may also explain why P. malariae was not diagnosed since 1959 in Costa Rica.
Referring to the samples studied, sample 1 belonged to a transfusional malaria case that presented all parasite stages in the blood smears, which facilitated the diagnosis, especially since this patient was also immunosuppressed because of cancer treatment. Sample 2 presented only immature trophozoite stages in the blood smears, making difficult to diagnose correctly the Plasmodium species until real-time PCR was carried out. Sample 3 was positive in real-time PCR but negative in microscopy, presenting a low parasitemia, and sample 4 presented parasitic stages which made possible the microscopic diagnosis.
The fact that the three samples showed 99% identity with chronic asymptomatic case and sample 4 to a clinical case, both detected in San Carlos, Alajuela, located in the northern part of the country.
Microscopic analysis
Thick and thin blood smears were prepared from each sample, stained with modified Romanowsky, and examined microscopically with the 100x immersion objective, to determine parasitological density and to identify species [8] . Density of parasites per microliter (µl) was determined by counting number of Plamodium parasites present in 100 leukocytes in relation to the white blood counts per µl of each patient, in high parasitemias 500 Plasmodium parasites were counted in present leukocytes [8] . Once a sample was determined positive by a trained and internationally certified microscopist in a local laboratory, another blood sample was taken within three days, and sent to CNRP-INCIENSA, the Reference Laboratory for Malaria, to carry out another slide reading, these blood samples were also used for molecular analysis.
DNA extraction
DNA extraction was performed using the column extraction kit GenElute (Sigma Aldrich) proceeding according to the manufacturer's instructions. DNA concentration was determined with the Nanodrop 2000.
Real-time PCR
The extracted DNA was analyzed using the real-time PCR protocol described by Veron et al. [1] , using species specific primers and species specific probes labeled with fluorochromes, targeting the 18S ribosomal RNA gene of Plasmodium (P. malariae, P. vivax, and P. falciparum). DNA of P. malariae donated by Center Disease Control (CDC) in Atlanta, USA, was used as positive control. Samples were amplified in the Step One Plus (Applied Biosystems) and amplification curves were analyzed with the software Step One. The number of amplification cycles required to reach the threshold of fluorescence (Ct values) of each sample was determined.
Sequencing and phylogenetic tree T h e D N A w a s s u b j e c t e d t o e n d p o i n t P C R , t o a mplif y a sequence of t he 18S rDNA gene t y pe A of
Plasmodium spp. [9] . The genus specific primers rPLU6 (5'-T TA A A AT TGT TG CAGT TA A A ACG -3 a nd rPLU5 (5'-CCTGTTTGTTGCCTTAAACTTC-3') were used [10] . Reactions with 12.5 µl Dream Taq™ PCR Master Mix 2X (Fermentas®), 1.0 µl of each primer (20 pmol/µl), 5 µl DNA (~50 µg) and 5.5 µl water (molecular biology grade, Fermentas®) were prepared to a final volume of 25 µl. Amplification protocol consisted of an initial denaturation at 95°C for 5 minutes, 35 cycles of denaturation (95°C for 1 minute), alignment (48°C for 1 minute), extension (72°C for 1 minute), and a final extension of 72°C for 5 minutes. DNA of P. vivax donated by CNRP-INCIENSA was used as positive control; water (molecular biology grade, Fermentas®) was used as negative control. The PCR products were visualized by agarose gel electrophoresis (1.4%) in TBE (Tris Base, boric acid, EDTA, pH8, 0.5M), and stained with GelRed™ Nucleic Acid Gel Stain (Biotium, 5 µg/ ml). GeneRuler 100 bp DNA Ladder Plus (Sm243, Fermentas®) was used as marker. Amplified fragments with a size of 1050 bp were considered positive and sent for its purification and sequencing to Macrogen (Seoul, Korea). Partial sequences were aligned with BioEdit Sequence Aligment Editor® and compared using the BLASTn algorithm with the database of NCBI (National Center for Biotechnology Information) [11] . Afterwards they were imported in MEGA 5 [12] , using the algorithm of Jukes and Cantor and the UPGMA method for the design of the phylogenetic tree [13, 14] . Ten thousand repetitions were calculated [15] . Reference sequences of the 18S rDNA genes of Plasmodium spp., available in the GenBank database, accession numbers AF145336, AF488000, AF487999 and M54897 (P. malariae), AF130735 (P. brasilianum), M19172 (P. falciparum) and AY579418 (P. vivax) were included in the analysis. The tree was compared with the 18S rDNA sequence of Babesia bovis (GenBank L19077) belonging to Haematozoa, sequences of P. brasilianum detected in non-human primates from French Guiana, coincides with what has been reported recently in the literature, that rainforest monkeys may represent a natural reservoir for human malaria [19] , and with what has been proposed in recent studies, that P. malariae might derive from P. brasilianum [5] . P. brasilianum was detected in Costa Rica in 2005 in howler monkeys using blood smears [3] .
It is important to notice, that the three samples also showed 99% of identity with a P. malariae detected in humans in New Guinea [19, 20] . Interestingly, those samples also showed 99% identity with two peculiar forms of P. malariae parasites found in Myanmar (Burma), whose morphologies of early trophozoite stages were distinct from that of the typical P. malariae [18] . Although PCR-based diagnosis confirmed these parasites as new variant forms of P. malariae they were separated into two genetic types that correlated with the two morphological types. The P. tenue-like type was closer to a monkey quartan malaria parasite, P. brasilianum. These results illustrate that the microscopic appearance of human P. malariae parasites may be more varied than previously assumed and emphasizes the value of molecular tools in the evaluation of malaria morphological variants [18] .
The sample with a negative result in blood smear (sample 3) had a low parasite count, only detectable with real-time PCR, and did correspond to a person with chronic asymptomatic P. malariae infection, who donated blood and transmitted the parasites to the patient of sample 1. According to the medical records, this donor suffered from fevers when young, also mild icterus was reported during those fevers, which made malaria a suspect, however, he never was subjected to a malaria test. The other two cases are not linked epidemiologically to the donor and the recipient, or between them. Sample 2 belonged to an elderly man (75 years old), that lived in Home Creek, Talamanca, that had never left the district and never experienced malaria before, while the latter case was a male, who indicated to have entered the forest and was bitten by mosquitoes few weeks before getting sick. The available data indicate that at least two cases may have been due long-term persistence of P. malariae in man (samples 2 and 3), whereas one case seemed to be related to forests and mosquitoes. The importance of these findings resides in that this is the first time that cases of P. malariae have appeared in Central America in a long time. Further studies have to determine if these were due to P. malariae's long recrudescence period or new cases. Elimination of P. malariae would require much more stringent parameters than P. falciparum or P. vivax, for this reason, the following measures were taken: From the year 2013 onwards, blood smears from suspicious clinical cases in Costa Rica are stained with Giemsa and analyzed microscopically. All positive samples and ten percent of negative samples are sent to CNRP-INCIENSA for confirmation with microscopic analysis, and Real Time PCR is carried out to confirm all positive samples.
Conclusions
For the first time since 1959, the present study reports the parasitological and molecular detection and characterization of P. malariae in humans in Costa Rica, Central America. It remains to elucidate in future studies, if P. malariae is reemerging in Costa Rica or has always been present, but was not microscopically diagnosed or misdiagnosed as P. vivax. It is recommended to improve the quality of microscopic analysis and confirm all microscopically positive Plasmodium results with real-time PCR in the future. 
